Inventor · Montréal, QC, CA

Julie Farand

18Patents
4h-index
59Co-inventors
59Inventor score

Filing activity: May 15, 2006 → Aug 22, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9376441B2 Substituted pyrrolidines as SYK inhibitors Chemistry; Metallurgy 13 Active
US11584738B2 LPA receptor antagonists and uses thereof Chemistry; Metallurgy 8 Active
US11136290B2 Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives Emerging Cross-Sectional Technologies 4 Active
US10005774B2 Syk inhibitors Chemistry; Metallurgy 4 Active
US11787825B2 Therapeutic compounds for HIV virus infection Chemistry; Metallurgy 4 Active
US11548871B2 Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof Chemistry; Metallurgy 3 Active
US8003661B2 Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists Chemistry; Metallurgy 1 Active
US11912686B2 LPA receptor antagonists and uses thereof Chemistry; Metallurgy 1 Active
US10329286B2 FXR (NR1H4) modulating compounds Chemistry; Metallurgy 1 Active
US11247986B2 FXR (NR1H4) modulating compounds Chemistry; Metallurgy 1 Active
US8013159B2 Quinoline derivatives as EP4 antagonists Human Necessities 1 Active
US12187753B2 Therapeutics compounds for HIV virus infection Human Necessities 0 Active
US12404262B2 Therapeutic compounds for HIV virus infection Chemistry; Metallurgy 0 Active
US8685999B2 Beta carboline sulphonylurea derivatives as EP4 receptor antagonists Human Necessities 0 Active
US11999717B2 Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof Chemistry; Metallurgy 0 Active
US12358903B2 FXR (NR1H4) modulating compounds Chemistry; Metallurgy 0 Active
US12084467B2 Therapeutic compounds for HIV virus infection Chemistry; Metallurgy 0 Active
US12049439B2 Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.